Lodestar Minerals has surged ~129% YTD after a breakout to ~$0.028, with potential upside toward $0.03–$0.04 if momentum continues. However, as an early-stage explorer, gains are likely event-driven and volatile, with sustainability dependent on exploration success.
Lynas Rare Earths (ASX: LYC) recently broke its short-term uptrend due to weak Q3 production, facility outages, and expansion costs. Technical analysis indicates strong downside momentum, with the next major support zone sitting lower around the $16.00–$16.23 level.
Meeka Metals faces selling pressure near key support after a volatile year, amid operational challenges and cautious sentiment. As it transitions to production at Murchison, investors are watching whether support holds or signals further downside despite long-term growth potential.
Orthocell is a regenerative medicine company expanding Remplir globally, but investors remain cautious because revenue growth is uneven, the business is still loss-making, and U.S. uptake may take time, leaving the stock a higher-risk turnaround opportunity.
Treasury Wine Estates shows early reversal signs after a downturn, supported by restructuring optimism and stabilising demand. Key upside lies around A$5.30–A$5.70, with further gains possible if momentum holds, though sustained strength is needed to confirm a broader recovery.
Cochlear’s share price slump reflects profit downgrades, slowing growth, weak global demand, and macro pressures. The stock is down sharply, but a lasting bottom likely depends on stabilising earnings and clearer signs of demand recovery.
